Harnessing Science and Innovation.Amgen, the world's largest independent biotechnology company, was founded in Thousand Oaks, California Thousand Oaks, commonly referred to as "T.O." by residents, is a city in southeastern Ventura County, California, in the United States. It was named after the many oak trees that grace the area, and the city seal is adorned with an oak. in 1980 as AMGen (Applied Molecular Genetics molecular genetics n. The branch of genetics that deals with hereditary transmission and variation on the molecular level. ). More than twenty years TWENTY YEARS. The lapse of twenty years raises a presumption of certain facts, and after such a time, the party against whom the presumption has been raised, will be required to prove a negative to establish his rights. 2. later, Amgen's aspiration to be the world's best human therapeutics company is closer than ever. The success of Amgen lies with its commitment to harness science and innovation to dramatically improve people's lives. It is a simple, yet powerful, direction that has helped Amgen employees develop values that guide business decisions as the company continues its search for breakthrough and important human therapeutics. The knowledge developed through the utilization of state of the art cellular and molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller enables Amgen scientists to discover and develop both naturally occurring proteins and small molecules as potential human therapeutics. Amgen currently markets two products: EPOGEN [R] (Epoetin alfa e·po·e·tin al·fa n. A recombinant preparation of human erythropoietin used to treat some forms of anemia. epoetin alfa Epogen, Eprex (CA) (UK), Procrit Pharmacologic class: ) and NEUPOGEN(r) (Filgrastim). Imagination, technical proficiency and dedication are the foundation for the development of the innovative pipeline candidates that will be part of Amgen's future. Looking forward, the company's search for breakthrough therapeutics remains broad and scientifically entrepreneurial. The focus of research and product development in areas such as chronic kidney disease Chronic kidney disease (CKD), also know as chronic renal disease, is a progressive loss of renal function over a period of months or years through five stages. Each stage is a progression through an abnormally low and progressively worse glomerular filtration rate, which is , inflammation, oncology and neurology may develop into products that can be used to treat disorders of the blood and bone marrow, cancer, bone and joint diseases, neurodegenerative diseases, such as Parkinson's disease, and obesity. |
|
||||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion